AGP Executive Report
Last update: 3 hours agoMaternal & emergency care upgrades: Malaysia’s MOH launched a custom sea ambulance and an Emergency Birthing Unit on Pulau Tuba, cutting referral delays for over 5,000 island residents. Healthcare capacity expansion: Nepal’s BPKIHS in Dharan got a fresh commitment for faster rollout of a new Maternal and Child Health centre and plans to add MRI services. Workforce & access via digital health: Pakistan’s Ahsan Iqbal urged overseas Pakistani doctors to back a “telemedicine backup” model—specialist panels supporting junior doctors in remote districts. AI in clinical care: Apollo Hospitals in Madurai rolled out AI-powered patient monitoring across all inpatient beds, aiming for earlier detection of deterioration. Drug development milestone: Celea Therapeutics secured $180M for a pivotal head-to-head Phase 3 trial of deupirfenidone versus pirfenidone for idiopathic pulmonary fibrosis. Regulation & fraud: Florida and Iowa took new steps to rein in pharmacy benefit managers and insurer interference, while the U.S. continues a broader healthcare fraud crackdown. Aging-care warning: A New England Journal of Medicine perspective flags a looming U.S. nursing home crisis as demand rises faster than beds and staffing. HIV treatment for newborns: FDA accepted a priority-review application to extend dolutegravir use to newborns from birth.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/df82d647-8fbc-4a91-8fdd-70591ce160c6/north-america-antidiabetic-drugs-market-size-2025-to-2035-usd-billion-.webp)
